• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years?

作者信息

Ahn Christina K, Holt Nicholas J, Tarr Phillip I

机构信息

Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8208, St. Louis, MO 63110, USA.

出版信息

Adv Exp Med Biol. 2009;634:1-17. doi: 10.1007/978-0-387-79838-7_1.

DOI:10.1007/978-0-387-79838-7_1
PMID:19280844
Abstract
摘要

相似文献

1
Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years?产志贺毒素大肠杆菌与溶血尿毒综合征：过去25年我们了解到了什么？
Adv Exp Med Biol. 2009;634:1-17. doi: 10.1007/978-0-387-79838-7_1.
2
Stratified therapy in Shiga toxin-producing Escherichia coli associated with hemolytic uremic syndrome.产志贺毒素大肠杆菌所致溶血尿毒综合征的分层治疗
Pediatr Int. 2020 Mar;62(3):305-306. doi: 10.1111/ped.14161.
3
Similarity of Shiga toxin-producing Escherichia coli O104:H4 strains from Italy and Germany.来自意大利和德国的产志贺毒素大肠杆菌O104:H4菌株的相似性。
Emerg Infect Dis. 2011 Oct;17(10):1957-8. doi: 10.3201/eid1710.111072.
4
Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature.老年人中与大肠杆菌O157:H7感染相关的溶血性尿毒症综合征：一例病例报告及文献综述
J Med Case Rep. 2016 Jun 15;10:175. doi: 10.1186/s13256-016-0970-z.
5
[Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].由产志贺毒素大肠杆菌引起的溶血性尿毒症综合征
Rev Prat. 2013 Jan;63(1):11-6.
6
Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.溶血性尿毒症综合征监测，以监测大肠杆菌O157:H7及其他产志贺毒素大肠杆菌感染的趋势。
Emerg Infect Dis. 1997 Jul-Sep;3(3):409-12. doi: 10.3201/eid0303.970329.
7
Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections.2000 - 2010年美国非O157产志贺毒素大肠杆菌感染的认知增加：流行病学特征及与O157大肠杆菌感染的比较
Foodborne Pathog Dis. 2013 May;10(5):453-60. doi: 10.1089/fpd.2012.1401. Epub 2013 Apr 6.
8
Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.小儿腹泻后溶血尿毒综合征中的感染：与鉴定产志贺毒素大肠杆菌相关的因素
Arch Pediatr Adolesc Med. 2012 Oct;166(10):902-9. doi: 10.1001/archpediatrics.2012.471.
9
Non-O157 Shiga-toxin-producing Escherichia coli.非O157产志贺毒素大肠杆菌
Lancet Infect Dis. 2012 Jan;12(1):12. doi: 10.1016/S1473-3099(11)70360-7.
10
Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.德国产志贺毒素大肠杆菌 O104:H4 疫情概况。
N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.

引用本文的文献

1
A Multi-Specific DARPin Potently Neutralizes Shiga Toxin 2 via Simultaneous Modulation of Both Toxin Subunits.一种多特异性抗肌动蛋白重复域蛋白通过同时调节两种毒素亚基有效中和志贺毒素2。
Bioengineering (Basel). 2022 Sep 27;9(10):511. doi: 10.3390/bioengineering9100511.
2
Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections.单克隆抗体用于治疗细菌感染的药代动力学和药效学考量
Antibodies (Basel). 2018 Jan 4;7(1):5. doi: 10.3390/antib7010005.
3
Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity.
肠出血性大肠杆菌 O157:H7 感染后溶血性尿毒症综合征的病例定义在有效性上存在差异。
Int J Med Microbiol. 2018 Dec;308(8):1121-1127. doi: 10.1016/j.ijmm.2018.10.002. Epub 2018 Oct 10.
4
Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti-Stx2 antibodies in mice.人/鼠嵌合抗志贺毒素1和抗志贺毒素2抗体在小鼠体内的保护效力及药代动力学
Clin Vaccine Immunol. 2015 Apr;22(4):448-55. doi: 10.1128/CVI.00022-15. Epub 2015 Feb 25.
5
Recent advances in understanding enteric pathogenic Escherichia coli.对肠致病性大肠杆菌的认识的最新进展。
Clin Microbiol Rev. 2013 Oct;26(4):822-80. doi: 10.1128/CMR.00022-13.
6
Shiga toxin pathogenesis: kidney complications and renal failure.志贺毒素发病机制：肾脏并发症和肾衰竭。
Curr Top Microbiol Immunol. 2012;357:105-36. doi: 10.1007/82_2011_172.
7
Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.腹泻期间早期容量扩张及随后溶血尿毒综合征期间的相对肾保护作用。
Arch Pediatr Adolesc Med. 2011 Oct;165(10):884-9. doi: 10.1001/archpediatrics.2011.152. Epub 2011 Jul 22.
8
Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.人类肠道组织和培养的结肠细胞含有神经节苷脂 GD3 合成酶 mRNA 和交替的志贺毒素受体神经节苷脂 GT4。
Infect Immun. 2010 Nov;78(11):4488-99. doi: 10.1128/IAI.00620-10. Epub 2010 Aug 23.
9
Prevalence of Stx phages in environments of a pig farm and lysogenic infection of the field E. coli O157 isolates with a recombinant converting Phage.猪场内环境中 Stx 噬菌体的流行情况及一株重组转化噬菌体对猪场内 O157 型大肠杆菌的溶原性感染。
Curr Microbiol. 2011 Feb;62(2):458-64. doi: 10.1007/s00284-010-9729-8. Epub 2010 Aug 10.